Predictive testing for Huntington's disease with use of a linked DNA marker.
about
Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington diseaseOpinion: predictive testing for Huntington disease in childhood: challenges and implicationsA worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.Different options for prenatal testing for Huntington's disease using DNA probesExclusion testing in pregnancy for Huntington's diseaseDemand for DNA probe testing in three genetic centres in Britain (August 1986 to July 1987)Emotional and functional impact of DNA testing on patients with symptoms of Huntington's diseaseConsiderations in using linkage analysis as a presymptomatic test for Huntington's diseaseA yeast artificial chromosome telomere clone spanning a possible location of the Huntington disease geneFamilial hypertrophic cardiomyopathy is a genetically heterogeneous diseaseTrinucleotide repeat length instability and age of onset in Huntington's disease.Huntington's disease and the ethics of genetic prediction.Linkage disequilibrium and modification of risk for Huntington disease.The paradigm of Huntington diseaseHuntington disease in Finland: linkage disequilibrium of chromosome 4 RFLP haplotypes and exclusion of a tight linkage between the disease and D4S43 locus.Discrimination as a consequence of genetic testing.Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.Improved predictive testing for Huntington disease by using three linked DNA markers.Clustering of multiallele DNA markers near the Huntington's disease gene.Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction ConsortiumMapping of D4S98/S114/S113 confines the Huntington's defect to a reduced physical region at the telomere of chromosome 4.Disease gene identification: ethical considerations.Genetic counseling and testing for Huntington's disease: A historical review.22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium.DNA sampling and informed consent.Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease.Innovations in human genetics education. Incorporation of genetics into a problem-based medical school curriculum.Attitudes of general practitioners to presymptomatic testing for Huntington's disease.Presymptomatic Diagnosis of Genetic Disorders: Is it worth the anxiety?Clinical consequences of isolating the gene for Huntington's disease.Predictive testing for Huntington's disease.Huntington's disease: predictive testing and the molecular genetics laboratory.Huntington's chorea: general practitioners' knowledge about individuals' at-risk status.Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).Predictive testing of minors for Huntington's disease: The UK and Netherlands experiences.Knowing for the sake of knowing: the value of prognostic informationEthical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group
P2860
Q24676732-434D1525-7DCB-41BD-8BFA-3CC4B89AF9D0Q24677475-C099DEFB-1D91-4BC7-A2C6-729943729FBFQ30446969-479E3C6A-E5B6-4663-9588-3B6CDBCEF4B4Q33592997-8BFC4175-8D20-45B3-9F73-65B4E1A9FD91Q33598047-0EEBDD59-C28B-4801-A422-17D944A584D3Q33598421-B869E92B-018A-4C82-92A9-827FEED10773Q33677075-A3F266D8-A2FC-4195-B8E6-05EB23B628EBQ33681810-4AF7CE29-CE3C-4B04-9276-4857098A98E4Q33839565-49A88296-D285-4805-99A7-DDE2C95B2761Q34260962-C996C614-20DB-4FD1-8A28-0BFF83F39C0CQ34357407-F4FCC3CF-D82A-4E88-B51D-4730245E01F2Q34383165-8FC51D66-F874-47DC-B41B-382CD37F49F1Q35196462-0934734D-1FE9-4BB1-817A-6DA2B09603F1Q35197253-62BA577D-0519-4CE6-B48F-407CA27B473FQ35197620-B76B116C-1037-4E14-B99B-1A7B30468566Q35199339-FBFD1914-2FED-40DA-B98A-1F288F16D73FQ35247419-725F1A00-CCBC-4FC7-B179-EB6A1C44173EQ35247741-E0A182EA-CE59-416C-961C-247001B5EBF9Q35814879-0E3636BA-4008-419C-A053-0A30E882A07CQ35821464-599A7E68-C4B0-40B8-8E7F-53FFDD20F828Q36080324-F45E66AC-4516-4490-858D-AE1E817A44E4Q37107577-7D4EA6A9-64E2-4D7F-96D1-312D14E8E6F5Q38833267-8411FB2F-0968-4DDA-B5BA-CDCB0F7DF9AFQ38869021-00DEB149-D662-4C3F-AA65-75939330E92DQ39212492-C2072B57-277F-4DB5-B8B2-C42BB17A1886Q40562181-400E2F05-BD13-4D36-AE55-E680C6B6325EQ40586576-CBAEFA78-C2DD-4CA2-AC92-7BF4B3B9C4CEQ41670868-2669EAAD-E2A7-46C5-B623-7767E4530514Q41819106-437B0C03-3CE2-4322-AF25-68B4FC56E0F1Q43152481-EEC03F7B-F5BB-4AD1-AF9D-F19AED869F5AQ43379823-048D3462-EEEA-4A62-9591-52E0CB446192Q45289748-98E2B528-6982-433E-BB03-4AA0F417972FQ45295578-EE573D66-13CD-47DF-9F74-C493553CDE88Q45298405-F3048B26-60AF-46AE-B760-49F56232988DQ47669611-83CD83FD-FAB2-457C-8506-9890EC55AE1CQ57272429-5691E1E0-ECF3-4778-A450-F3DCA1A43D7BQ58681325-3951A20B-9BDB-495E-B986-97346DC42EB9
P2860
Predictive testing for Huntington's disease with use of a linked DNA marker.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Predictive testing for Huntington's disease with use of a linked DNA marker.
@en
Predictive testing for Huntington's disease with use of a linked DNA marker.
@nl
type
label
Predictive testing for Huntington's disease with use of a linked DNA marker.
@en
Predictive testing for Huntington's disease with use of a linked DNA marker.
@nl
prefLabel
Predictive testing for Huntington's disease with use of a linked DNA marker.
@en
Predictive testing for Huntington's disease with use of a linked DNA marker.
@nl
P2093
P50
P1476
Predictive testing for Huntington's disease with use of a linked DNA marker.
@en
P2093
Klinger KW
Koroshetz WJ
Mastromauro CA
Meissen GJ
Watkins PA
P304
P356
10.1056/NEJM198803033180903
P407
P577
1988-03-01T00:00:00Z